IV tissue plasminogen activator (tPA) is a safe and effective therapy for acute ischemic stroke when administered within established time windows. The main complication from administration of tPA is ...
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Treatment of stroke with tissue plasminogen activator within 4.5 hours of stroke onset reduces ...
Emergency mobile stroke unit. Ambulance van furnishes services to diagnose stroke patients. Two neurologists discuss the barriers to timely tPA administration in acute stroke, including the ...
Moreover, tPA has inherent neurotoxic actions that counteract some of the therapeutic benefits of the drug. Armstead et al. have found that administration of the small peptide EEIIMD with tPA reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results